Le Lézard
Classified in: Health
Subject: PDT

InventHelp Inventor Develops Modified Automated External Defibrillator (SDK-110)


PITTSBURGH, April 17, 2024 /PRNewswire/ -- "I thought there should be a way to automatically call 911 when using an AED to help someone suffering a heart attack," said an inventor, from Shoreline, Wash., "so I invented the A E D G P S. My design enables you to assist someone and it offers peace of mind knowing first responders have already been contacted and will be arriving shortly."

The invention provides an improved design for an Automated External Defibrillator (AED). In doing so, it ensures that 911 or first responders are contacted if activated during an emergency. As a result, it enhances safety and convenience, and it eliminates the need to manually call for help. The invention features an automatic design that is easy to use so it is ideal for businesses and commercial facilities with AEDs.

The original design was submitted to the National sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 22-SDK-110, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

SOURCE InventHelp


These press releases may also interest you

at 05:05
Sphere Fluidics Appoints Dale Levitzke as Chief Executive Officer
Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Dale Levitzke as CEO with immediate effect, as Dr. Frank F. Craig, current CEO and co-founder,...

at 05:05
Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb
Scenic Biotech, a pioneer in the field of modifier therapies for severe genetic disorders, today announced that it has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb's drug...

at 05:00
PetSafe® introduces its latest pet tech innovation with the world's first pumpless pet fountain
As PetSafe® continues to lead the way in pet-tech innovations, we are proud to introduce the next evolution in pet fountains: the PetSafe® Outlasttm 90 oz Pumpless Pet Fountain with patented HydroSpintm technology....

at 05:00
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg
BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany. The main objective of the project is to develop novel immunotherapeutic strategies to...

at 04:52
Foresee Pharmaceuticals Announces First Subject Dosed in its First-in-Human Clinical Trial of FP-020
Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP-020 in Australia. The Phase 1 clinical trial is a randomized, double-blind, placebo-controlled,...

at 04:09
Innovation showcase displays growing influence
A news report from China Daily: The 2024 ZGC Forum in Beijing showcased a wide range of latest technological innovations. The event ran from April 25 to 29 and comprised 128 activities, including forums and conferences, technology exchanges,...

More news about Health...


News published on and distributed by: